Skip to main content
Canna~Fangled Abstracts

Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview

By December 11, 2023December 19th, 2023No Comments

Review

doi: 10.1007/s11864-023-01146-4.

Online ahead of print.
Affiliations 

Abstract

Pancreatic cancer (PC) remains the deadliest cancer worldwide. Most patients are diagnosed at the advanced or metastatic stage, leading to a poor prognosis. Awareness of the limitations of current therapy and accompanying pain, depression, malnutrition, and side effects of chemoradiotherapy may lead patients and physicians towards complementary and alternative medicine (CAM). CAM refers to a diverse set of medical and healthcare practices, products, and systems that are not part of conventional Western medicine. Despite the low-quality evidence supporting the efficacy of these methods, they remain appealing due to patients’ beliefs, fear of death, and the slow development of conventional therapy. Hence, the possibility of using natural products for pancreatic cancer is increasing. CAM options such as: medical cannabis, plants, fungi, herbal formulas, and injections, which originate primarily from traditional Chinese or Japanese medicine i.e. Curcuma longa, Panax ginseng, Poria cocos, Hochuekkito, Juzentaihoto, and Rikkunshito, Shi-quan-da-bu-tang/TJ-48, Huang-qin-tang, Shuangbai San, Wen Jing Zhi Tong Fang, Xiang-Sha-Liu-jun-zi-tang, Aidi injection, Brucea javanica oil emulsion/Yadanziyouru injection, Compound Kushen injection, Huachansu injection, Kangai injection and Kanglaite injections are becoming promising candidates for the management of pancreatic cancer. The abovementioned substances/medications are the most popular or potentially effective in PC treatment and consequently CAM-based adjuvant therapy through improving patients’ quality of life, might be a useful addition in the treatment of pancreatic cancer patients.

Keywords: Complementary and alternative medicine; Pancreatic cancer; Traditional Chinese medicine; Treatment of pancreatic cancer.

PubMed Disclaimer

References

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. ‘Cancer Today’. [Online]. Available: https://gco.iarc.fr/today/home . [Accessed: 29-Jul-2022].
    1. Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. Rev World J Oncol. 2019;10(1):10–27. – DOI
    1. O’Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2008;34(3):324–32. – PubMed – DOI
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654 . Epub 2021 Jan 12. Erratum in: CA Cancer J Clin. 2021 Jul;71(4):359
    1. Meng Q, et al. Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis. J Cancer. 2017;8(17):3615–22. – PubMed – PMC – DOI

Publication types

LinkOut – more resources


Leave a Reply